| Application no. and date | 17192971.4 (espacenet) (Federated) (European Patent Register), 20060411 | | Patent/reg. no. and date | DK/EP 3321359, 20201202 | | Publication date | 20180516 | | Priority no. and date | US 670573 P, 20050411 | | EP pub. no. and date |
EP 3321359 20180516 | | Effective date | | | Applicant/owner | Horizon Therapeutics USA, Inc., 1 Horizon Way
Deerfield, Illinois 60015, US | | Applicant ref. no. | P75920DK01 | | Inventor | HARTMAN, Jacob, 12b Igael Yadin Street
58453 Holon, IL,
MENDELOVITZ, Simona, 42 Tagore Street
69341 Ramat Aviv, IL | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 47/60 (2017.01) , C12N 9/06 (2006.01) | | Title | VARIANTE FORMER AF URATOXIDASE OG ANVENDELSE DERAF | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
